Item Type | Name |
Concept
|
Hepatitis, Alcoholic
|
Concept
|
Liver Cirrhosis, Alcoholic
|
Concept
|
Liver Diseases, Alcoholic
|
Academic Article
|
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
|
Academic Article
|
Non-alcoholic fatty liver disease: is bariatric surgery the answer?
|
Academic Article
|
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
|
Academic Article
|
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
|
Academic Article
|
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.
|
Academic Article
|
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
|
Academic Article
|
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis.
|
Academic Article
|
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
|
Academic Article
|
Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.
|
Academic Article
|
Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.
|
Academic Article
|
Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study.
|
Academic Article
|
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
|
Academic Article
|
Non-alcoholic fatty liver disease.
|
Academic Article
|
Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
|
Academic Article
|
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
|
Academic Article
|
Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
|
Academic Article
|
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD.
|
Academic Article
|
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD.
|
Academic Article
|
Nonalcoholic fatty liver disease: a systematic review.
|
Academic Article
|
Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
|
Academic Article
|
Preparing for the NASH epidemic: A call to action.
|
Academic Article
|
Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
|
Academic Article
|
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
|
Academic Article
|
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
|
Academic Article
|
Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
|
Academic Article
|
Preparing for the NASH Epidemic: A Call to Action.
|
Academic Article
|
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
|
Academic Article
|
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.
|
Academic Article
|
Twenty-five-year trajectories of insulin resistance and pancreatic ß-cell response and diabetes risk in nonalcoholic fatty liver disease.
|
Academic Article
|
The role of diet and nutrient composition in nonalcoholic Fatty liver disease.
|
Academic Article
|
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.
|
Academic Article
|
Moderate Exercise for Nonalcoholic Fatty Liver Disease.
|
Academic Article
|
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
|
Academic Article
|
Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy-proven nonalcoholic steatohepatitis.
|
Academic Article
|
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.
|
Academic Article
|
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum.
|
Academic Article
|
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
|
Academic Article
|
Preparing for the NASH Epidemic: A Call to Action.
|
Academic Article
|
Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.
|
Academic Article
|
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
|
Academic Article
|
Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.
|
Academic Article
|
Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
|
Academic Article
|
Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
|
Academic Article
|
A myriad of pathways to NASH.
|
Academic Article
|
NAFLD: Reporting Histologic Findings in Clinical Practice.
|
Academic Article
|
Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis.
|
Academic Article
|
Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
|
Academic Article
|
Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
|
Academic Article
|
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
|
Academic Article
|
Preparing for the NASH epidemic: A call to action.
|
Academic Article
|
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
|
Academic Article
|
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
|
Academic Article
|
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.
|
Academic Article
|
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
|
Academic Article
|
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach.
|
Academic Article
|
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium.
|
Academic Article
|
Fatty Liver Disease: Diagnosis and Stratification.
|
Academic Article
|
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
|
Academic Article
|
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
|
Academic Article
|
Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey.
|
Academic Article
|
The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United States.
|
Concept
|
Non-alcoholic Fatty Liver Disease
|
Academic Article
|
Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
|
Academic Article
|
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers.
|
Academic Article
|
Recurrent NAFLD post-LT: Sisyphus' boulder or Proteus' parable?
|
Academic Article
|
Reply: People living with HIV and NAFLD and updated guidance on NAFLD screening.
|
Academic Article
|
Natural history of NASH cirrhosis in liver transplant waitlist registrants.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.
|
Academic Article
|
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
|
Academic Article
|
Pegozafermin for NASH - A Sprint to Start a Marathon.
|
Academic Article
|
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
|
Academic Article
|
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.
|
Academic Article
|
Implementation of a liver health check in people with type 2 diabetes.
|
Academic Article
|
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
|
Academic Article
|
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.
|
Academic Article
|
Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction.
|
Academic Article
|
Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers.
|
Academic Article
|
Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.
|